Telemedicine is a high priority but the market remains immature, Sage Growth Partners reports

By Catherine Sturman
With increased potential for new technologies to reshape the healthcare industry, Sage Growth Partners have looked at the way telemedicine will seek to...

With increased potential for new technologies to reshape the healthcare industry, Sage Growth Partners have looked at the way telemedicine will seek to take the industry into the next century, with increased demand for direct-to-consumer (DTC) technologies.

The survey, Defining Telemedicine’s Role: The View from the C-Suite, looks at how the emergence of new technologies, from electronic medical records, to diagnostic imaging services, will significantly impact the way in which patients are treated in the future.

Despite this. limited budgets, resources, changing regulations and continual concerns surrounding access to universal healthcare coverage for those in areas of poor healthcare infrastructure, have led providers to hold back on adopting telemedicine services.

With research conducted with over 100 healthcare executives, the survey looks at how telemedicine will transform the delivery of patient care. Over half of its respondents (56%) have stated that telemedicine has been adopted at their organisations, whilst the majority of non-adopters have placed it as a priority.

Highlighting the long-term potential to connect patients to providers and reshape specialist areas of care, such as neurology or neonatology, increased data protection and integration remain key drivers in the adoption of new healthcare services and solutions.

See also

“On the higher end of the acuity spectrum, emergent use cases such as telestroke have become more mature, to the point that they are widely acknowledged to have transformed the standard of care,” the report states.

“On the other hand, the value proposition of in-home remote patient monitoring (RPM) is evolving under value-based reimbursement, as organisations seek to enable elderly patients to age at home as they attempt to manage the total cost of care, often spurred by triggering events such as financial penalties for readmissions.”

A high number of healthcare providers are either working, or planning to work with a number of vendors to implement new, telemedicine solutions to support the growth of a consumer-centric healthcare model.

“We are looking at telemedicine as a program that can expand our reach, making it more convenient for existing patients, or allowing us to attract new patients into our system. With millennials, being seen at their convenience is more important than building a relationship with a physician over time,” one COO who undertook the survey has noted.

Surprisingly, the majority of healthcare professionals surveyed have also stated that although building a solution in house would lower costs of implementing telemedicine solutions, it would have limited resources in maintaining such a complex technology. Over half of healthcare executives surveyed have partnered with telemedicine vendors who can provide the required expertise to deliver a comprehensive solution across its healthcare domains.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare